
|Articles|October 3, 2007
Warfarin sensitivity test approved
FDA approves Verigene test for warfarin (Coumadin) metabolism
Advertisement
The Verigene Warfarin Metabolism Nucleic Acid Test, from Nanosphere, that detects variants in CYP2C9 and VKORC1 genes, has been approved by the FDA. The test helps clinicians determine which patients may not metabolize warfarin normally due to a gene variation. In August, the FDA updated the prescribing information to include an explanation on how the variants can affect metabolism of the drug.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































